Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

94.80
+3.684.04%
Post-market: 95.350.5500+0.58%18:45 EDT
Volume:4.91M
Turnover:459.17M
Market Cap:5.93B
PE:-22.80
High:98.80
Open:93.83
Low:88.48
Close:91.12
52wk High:98.80
52wk Low:10.94
Shares:62.58M
Float Shares:40.29M
Volume Ratio:0.50
T/O Rate:12.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:97.10
PE(LYR):-21.93

Loading ...

Kodiak Sciences Inc. Director Felix J. Baker acquired 639,386 shares.

Filings Track
·
2 hours ago

Baker Bros. Advisors Buys $32.31 Million of Kodiak Sciences Common Shares

Reuters
·
2 hours ago

Movement Alert|Kodiak Sciences Inc. Rises 6.48% in Regular Trading, Phase 3 Clinical Success Continues to Lift Shares

Market Focus
·
Yesterday

Kodiak Sciences Inc. : JP Morgan Raises Target Price to $124 from $69

THOMSON REUTERS
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 5.21% in Regular Trading, Pullback After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 5.36% in Pre-Market Trading, Profit-Taking After 172% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 7.83% Overnight, Retreating After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

NASD Most Active Issues

Dow Jones
·
Sep 29

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Reuters
·
Sep 29

Kodiak Sciences price target raised to $112 from $56 at Jefferies

TIPRANKS
·
Sep 29

Kodiak Sciences Price Target Raised to $96.00/Share from $58.00 by HC Wainwright & Co.

Dow Jones
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

TIPRANKS
·
Sep 29

Kodiak Sciences Inc. : H.c. Wainwright Raises Target Price to $96 from $58

THOMSON REUTERS
·
Sep 28

Top Midday Stories: MongoDB CEO Leaves to Lead Meta Enterprise Platform; Nvidia Ups Buyback Program by $150 Billion

MT Newswires Live
·
Sep 28

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28

Movement Alert|Kodiak Sciences Inc. Surges 146.43% in Regular Trading, Two Eye Drug Candidates Meet Primary Endpoints in Phase 3 Trial

Market Focus
·
Sep 28

Kodiak Sciences Shares Hit 52-Week High After Positive Phase 3 Trial

Dow Jones
·
Sep 28

Kodiak Sciences up Nearly 154%, on Pace for Record Percent Increase

Dow Jones
·
Sep 28

Kodiak Sciences rises 136.7%

TIPRANKS
·
Sep 28